Aveanna Healthcare: Q3 Beat And Higher Guidance Back Strong Buy Rating
Aveanna Healthcare (AVAH) reported Q3 earnings beat with 11% revenue growth and 25% adjusted EBITDA increase. Private duty services drove growth, with hours of care up 13 million. The company maintained a Strong Buy rating due to strong growth and profitability.
